Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (terbuka di window baru)

Barillari G, Pasca S, Barillari A, De Angelis V.

Sumber‎: Blood Transfus 2012;10(1):87-94.

Index‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (terbuka di window baru)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (terbuka di window baru)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Sumber‎: Chest 2012;141(2 Suppl):e326S-50S.

Index‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (terbuka di window baru)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (terbuka di window baru)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Sumber‎: Lancet 2015;385(9982):2077-87.

Index‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (terbuka di window baru)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (terbuka di window baru)

Hanke AA, Joch C, Görlinger K.

Sumber‎: Br J Anaesth 2013;110(5):764-72.

Index‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (terbuka di window baru)

Emergency reversal of warfarin anticoagulation. (terbuka di window baru)

Lin Y, Callum J.

Sumber‎: CMAJ 2010;182(18):2004.

Index‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (terbuka di window baru)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (terbuka di window baru)

Mo Y, Yam FK.

Sumber‎: Pharmacotherapy 2015;35(2):198-207.

Index‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (terbuka di window baru)

Idarucizumab for dabigatran reversal - full cohort analysis. (terbuka di window baru)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Sumber‎: N Engl J Med 2017;377(5):431-41.

Index‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (terbuka di window baru)

Oral anticoagulation in surgical procedures: risks and recommendations. (terbuka di window baru)

Torn M, Rosendaal FR.

Sumber‎: Br J Haematol 2003;123(4):676-82.

Index‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (terbuka di window baru)